Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_assertion type Assertion NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_head.
- NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_assertion description "[The meta-analysis of all the studies revealed that the rs4430796 polymorphism was significantly associated with an increased risk of prostate cancer in all contrast models (ORA vs G = 1.25, 95%CI = 1.21-1.30, POR < 0.001; ORAA vs GG = 1.53, 95%CI = 1.45-1.62, POR < 0.001; ORAG vs GG = 1.24, 95%CI = 1.16-1.34, POR < 0.001; ORAA vs AG+GG = 1.36, 95%CI = 1.30-1.42, POR < 0.001; ORAA+AG vs GG = 1.37, 95%CI = 1.30-1.44, POR < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_provenance.
- NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_assertion evidence source_evidence_literature NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_provenance.
- NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_assertion SIO_000772 25177939 NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_provenance.
- NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_assertion wasDerivedFrom befree-2016 NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_provenance.
- NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_assertion wasGeneratedBy ECO_0000203 NP1215909.RASLbYN-MNiqjuPf8_pzZWhucgyQGnpGLFaxeRDhjx7GI130_provenance.